Jim Simons acquired 165 Thousand Verve Therapeutics shares worth $1.08 Million. That's 0.00% of their equity portfolio (2222nd largest holding). The first Verve Therapeutics trade was made in Q4 2021. Since then Jim Simons bought shares two more times and sold shares on two occasions. The investor's estimated purchase price is $2.04 Million, resulting in a loss of 47%.